Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer.
Saved in:
| Title: | Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer. |
|---|---|
| Authors: | Solzak JP; Department of Surgery, Indiana University School of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN USA., Atale RV; Department of Surgery, Indiana University School of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN USA., Hancock BA; Department of Surgery, Indiana University School of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN USA., Sinn AL; In Vivo Therapeutics Core, Indiana University Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN USA., Pollok KE; In Vivo Therapeutics Core, Indiana University Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN USA.; Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Section of Pediatric Hematology/Oncology, Riley Hospital for Children at Indiana University Health Department of Pharmacology and Toxicology, Indianapolis, IN USA., Jones DR; Department of Medicine, Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN USA., Radovich M; Department of Surgery, Indiana University School of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN USA. |
| Source: | NPJ breast cancer [NPJ Breast Cancer] 2017 Apr 26; Vol. 3, pp. 17. Date of Electronic Publication: 2017 Apr 26 (Print Publication: 2017). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: eCollection Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 28649657 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Solzak+JP%22">Solzak JP</searchLink>; Department of Surgery, Indiana University School of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN USA.<br /><searchLink fieldCode="AU" term="%22Atale+RV%22">Atale RV</searchLink>; Department of Surgery, Indiana University School of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN USA.<br /><searchLink fieldCode="AU" term="%22Hancock+BA%22">Hancock BA</searchLink>; Department of Surgery, Indiana University School of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN USA.<br /><searchLink fieldCode="AU" term="%22Sinn+AL%22">Sinn AL</searchLink>; In Vivo Therapeutics Core, Indiana University Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN USA.<br /><searchLink fieldCode="AU" term="%22Pollok+KE%22">Pollok KE</searchLink>; In Vivo Therapeutics Core, Indiana University Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN USA.; Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Section of Pediatric Hematology/Oncology, Riley Hospital for Children at Indiana University Health Department of Pharmacology and Toxicology, Indianapolis, IN USA.<br /><searchLink fieldCode="AU" term="%22Jones+DR%22">Jones DR</searchLink>; Department of Medicine, Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN USA.<br /><searchLink fieldCode="AU" term="%22Radovich+M%22">Radovich M</searchLink>; Department of Surgery, Indiana University School of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101674891%22">NPJ breast cancer</searchLink> [NPJ Breast Cancer] 2017 Apr 26; Vol. 3, pp. 17. <i>Date of Electronic Publication: </i>2017 Apr 26 (<i>Print Publication: </i>2017). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Breast+Cancer+Research+Foundation%22">Breast Cancer Research Foundation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101674891 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2374-4677 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223744677%22">23744677 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Breast Cancer <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28649657 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41523-017-0016-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 17 Titles: – TitleFull: Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Solzak JP – PersonEntity: Name: NameFull: Atale RV – PersonEntity: Name: NameFull: Hancock BA – PersonEntity: Name: NameFull: Sinn AL – PersonEntity: Name: NameFull: Pollok KE – PersonEntity: Name: NameFull: Jones DR – PersonEntity: Name: NameFull: Radovich M IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 04 Text: 2017 Apr 26 Type: published Y: 2017 Identifiers: – Type: issn-print Value: 2374-4677 Numbering: – Type: volume Value: 3 Titles: – TitleFull: NPJ breast cancer Type: main |
| ResultId | 1 |
